Schistosomiasis Workup
- Author: Shadab Hussain Ahmed, MD, FACP, FIDSA, AAHIVS; Chief Editor: Burke A Cunha, MD more...
Approach Considerations
Blood tests are occasionally useful in supporting the diagnosis or assessing the severity of schistosomal infection. Serologies and polymerase chain reaction (PCR) assay–based testing can confirm a diagnosis.[37, 38] Considerations in laboratory testing include the following:
- Complete blood count (CBC) - May reveal peripheral eosinophilia, particularly in acute infection and/or anemia
- Increased alkaline phosphatase level and gamma-glutamyltransferase (GGT) level - Are observed with hepatic granulomatosis
- Transaminase levels - Generally are not affected, and elevations are usually caused by coexisting hepatitis
- Renal function - May be decreased if obstructive nephropathy is severe
- Blood cultures - Are indicated for patients with persistent or recurrent fever and for persons who may have developed recurrent Salmonella infection with severe enteric schistosomiasis
Acute illness is often associated with eosinophilia in the blood and tissues. With chronic illness, peripheral eosinophilia may be minimal or absent, while tissue eosinophilia persists.
Urinary and fecal microbiology
Urinary microbiology is key when diagnosing vesicular infection from S haematobium. Gross and microscopic hematuria is common. Concentration methods may be necessary, and a rough determination of egg load can be obtained. However, this should not be used as a firm measure of disease severity, as egg counts can vary markedly between specimens in a single patient.
Fecal microbiology, usually on thick smears, is essential when diagnosing schistosomiasis with primary bowel infection. Stool specimens may be positive for heme or grossly bloody. Concentration methods will be needed to identify light infestations. Rough quantitation can also be performed in these specimens with the same limitation as above.
In an experienced lab, morphologic details and staining can identify single and mixed schistosomal species in an infected individual.
PCR assay
Using patient urine samples, polymerase chain reaction (PCR) assay was 94.4% sensitive and 99.9% specific for the diagnosis of schistosomiasis.[37] PCR can detect and quantify schistosome deoxyribonucleic acid (DNA) in stool or urine.[39]
Stool or Urinary Analysis
Identify and speciate the eggs in the stool or urine. Quantification of the egg excretion is calculated by collecting 24-hour urine or stool, homogenizing the sample, and counting the eggs in a measured sample. Urine or stool egg count in a 24-hour collection quantitates the severity of the infection. (However, urinary excretion of eggs is not uniform. The urine is most likely to be positive for S hematobium from 10 am until 2 pm.[40] )
Fewer than 100 eggs per gram of stool or 10mL of urine indicates a light infection; 100-400 eggs per gram of stool or 10mL of urine indicates a moderate infection, and more than 400 eggs per gram of stool or 10mL of urine indicates a heavy infection.
Determination of the intensity of infection is an important tool in endemic areas, as many of the complications of schistosomiasis are related to the parasite burden. Intensity determination is made via quantitative sampling of 20-50g of stool (Kato-Katz technique) or a standardized volume of urine through a Nuclepore membrane.[41]
Egg Viability Test
This test is important for assessing the effectiveness of treatment. Because persons with inactive infection may continue to shed dead eggs into stool and urine for months, tests for egg viability, such as egg hatching or microscopic examination of eggs for the movement of flame cells, should be performed.
Viability testing requires mixing the stools or urine with room-temperature distilled water and observing for hatching miracidia. An active infection produces viable eggs, while treated or past infection results in nonviable eggs and an absence of miracidia.
Urinary Schistosomiasis
The following tests are performed in the diagnosis of urinary schistosomiasis:
- Urinary analysis and culture for hematuria, proteinuria, leukocyturia, and associated urinary infections
- Urinary syringe filtration techniques - Provide a quantitative estimate of eggs in the urine
- Blood chemistries, including renal function tests - Should include blood cultures for Salmonella bacteremia and a CBC for anemia and eosinophilia (a Salmonella urinary tract infection should always lead to suspicion of schistosomiasis)
Intestinal and Liver Schistosomiasis
Points to consider in testing for intestinal and liver schistosomiasis include the following:
- Direct stool examination is not a sensitive test for intestinal and liver schistosomiasis (both of which occur in chronic disease)
- Concentration techniques, such as a Kato-Katz thick smear, are needed; this demonstrates the number of eggs excreted per day
- Blood in the stool should be ruled out
- Tests should include a CBC for anemia and eosinophilia
- Thrombocytopenia is secondary to splenic sequestration
- Additional testing for HIV and HPV should be considered in female genital schistosomiasis
- Diagnostic tests for hepatitis B and C should be considered in liver schistosomiasis
Liver function test results usually are within the reference range until the end stage of disease. Mild elevation of alkaline phosphatase and gamma-glutamyl transferase levels may occur. If liver function test results are abnormal, look for other co-infections or diseases.
Serology
Antibody testing is epidemiologically useful but cannot be used to differentiate active and past illness. It also does not allow quantification of egg burden.
Serologic findings can be used to reach a diagnosis in a patient from a nonendemic area, because a negative antibody test result would be expected.
Detection of antibodies to S mansoni, S haematobium, and S japonicum adult worm microsomal antigens (ie, mansoni adult worm microsomal antigen [MAMA], haematobium adult worm microsomal antigen [HAMA], japonicum adult worm microsomal antigen [JAMA]) has been reported to be highly specific for all 3 species when the Falcon assay screening test (FAST), enzyme-linked immunoassay (ELISA), and immunoblot assays have been used.[42]
The sensitivity and specificity of ELISA tests currently in use are generally reported to be greater than 90% and 95%, respectively. Western blot tests are often used to confirm ELISA results.[43]
Antibody tests are generally negative during the acute presentation of Katayama syndrome, although serology often becomes positive before eggs become detectable. Seroconversion generally occurs 4-8 weeks after infection.
Antigen Tests
Because these tests measure parasite antigen as opposed to host antibody response, they reflect active infection. The tests are still investigational. With effective treatment, a reduction in antigenemia is expected.
The 2 proteoglycan, gut-associated antigens that appear most promising are circulating anodic antigen (CAA) and circulating cathodic antigen (CCA). These antigens can be found in urine or serum.[44]
Studies are underway to evaluate the sensitivity and specificity of these investigational antigen tests. A reagent strip using monoclonal antibodies to detect somatic schistosome antigens in urine has a sensitivity of more than 85% and is suitable for use in the field.[45]
Antigen titers also correlate well with the determination of infection intensity by egg counts and with clinical severity of disease.[46]
Antigen titers can be used to assess treatment efficacy posttherapy, since loss of circulating antigens indicates cure. Antigen tests may become negative as early as 5 to 10 days posttreatment.[44]
Imaging Studies
Ultrasonography (US) is a sensitive means of assessing hepatosplenic disease with periportal fibrosis or urinary obstruction. It can demonstrate periportal fibrosis, splenomegaly, portal collaterals, periportal adenopathy, ureteral obstruction, and obstructive nephropathy.
Echocardiography and/or invasive hemodynamic studies can demonstrate pulmonary hypertension and cor pulmonale, if present.
Chest radiographs may show patchy infiltrates in acute schistosomiasis and can indicate pulmonary hypertension and cor pulmonale in end-stage chronic infection, if present.
Computed tomography (CT) or magnetic resonance imaging (MRI) scanning may be useful in the evaluation of CNS disease or in the detection of periportal fibrosis.
Acute schistosomiasis
With acute schistosomiasis, a chest radiograph sometimes demonstrates a generalized increase in vascular and interstitial marking and mild lymphadenopathy.
Urinary schistosomiasis
Imaging tests for urinary schistosomiasis can include the following:
- Plain abdominal radiography - May demonstrate bladder and ureteral calcifications; the characteristic appearance is often referred to as "fetal head" calcification
- Ultrasonography - Hydronephrosis, hydroureters, and bladder wall irregularities may be visible
- Urography - May demonstrate abnormalities in the ureter and bladder wall
- Intravenous pyelography (IVP) - Ureteric strictures may be detected
Liver and intestinal schistosomiasis
Imaging tests for liver and intestinal schistosomiasis can include the following:
- Barium swallow or endoscopy - Esophageal varices are visualized[47]
- Ultrasonography of the liver and spleen - Used to reach an early and accurate diagnosis of periportal fibrosis and a diagnosis of hepatosplenomegaly and ascites
- CT scanning of the liver - Calcified capsules and septa are visible
- Contrast studies of the intestine - Mucosal irregularities are revealed
Lung schistosomiasis
Imaging tests for lung schistosomiasis include the following:
- CT scanning - May demonstrate early interstitial fibrosis.
- Echocardiography - Findings reflect pulmonary hypertension due to egg emboli to pulmonary vasculature
CNS schistosomiasis
A CT or MRI scan of the brain and spinal cord may show lesions in CNS schistosomiasis. Nodular and ring-enhancing lesions with surrounding edema are seem on CT and MRI brain scans. Eggs reach the lower spinal cord through the Batson plexus with S haematobium and S mansoni infection. These produce granulomatous lesions of the cauda equine and conus medularis.
Biopsy and Other Procedures
Biopsy is helpful when stool sample findings are negative or in light infection. Mucosal biopsy is effective for visualizing eggs. Obtain multiple biopsy samples and crush them between slides to increase egg-detecting sensitivity. In one study, 61% of patients had eggs detected on rectal biopsy, whereas only 39% of patients had ova detected in stool.[48]
Liver biopsy has also been used for egg detection and may be appropriate in patients with unclear diagnoses or suspected co-infections.
Procedures used in the diagnosis of schistosomiasis include the following:
- Sigmoidoscopy/proctoscopy - Can be used to obtain mucosal biopsies (including rectal) for diagnosis and to identify complications such as pedunculated and sessile polyps
- Cystoscopy - Cystoscopy may be useful in schistosomiasis with primary bladder involvement for definitive diagnosis or to evaluate secondary ulcers and polyps, to biopsy for malignancy, to rule out other sources of hematuria and dysuria, and to identify eggs in mucosal biopsy specimens
- Surgical biopsy - Findings may be used to diagnose ectopic schistosomiasis
- Bronchoscopic washings or transbronchial biopsies - Eggs can be detected in individuals with pulmonary involvement[49, 50]
- Lumbar puncture - Eosinophils may be present in the cerebrospinal fluid (CSF) of individuals with neurologic involvement. One review showed that 41% of individuals with spinal cord involvement had eosinophils present in their CSF; 85% of these patients also had antischistosomal antibodies detected in spinal fluid.[51]
- Upper endoscopy - Can assess for esophageal varices; treat upper intestinal bleeding with endoscopic sclerotherapy
Scistosomiasis, Fact Sheet No 115; Feburary 2010. World Health Organization. Available at http://www.who.int/mediacentre/facesheets/fs115/en/index.html. Accessed Oct 5,2010.
Weekly epidemiological record 30 April No.18,2010, 85, 157-164. World health Organization. Available at http://www.who.int/wer. Accessed Sept. 27,2010.
[Best Evidence] Nawal M. Nour. Schistosomiasis: Health Effects on Women. Reviews in Obstetrics & Gynecology. 2010;3:28-32.
Corachan M. Schistosomiasis and international travel. Clin Infect Dis. Aug 15 2002;35(4):446-50. [Medline].
Houston S, Kowalewska-Grochowska K, Naik S, McKean J, Johnson ES, and Warren K. First Report of Schistosoma mekongi Infection with Brain Involvement. Clinical Infectious Diseases. 2004;38:e1-6.
Mohammed AZ, Edino ST, Samaila AA. Surgical pathology of schistosomiasis. J Natl Med Assoc. May 2007;99(5):570-4. [Medline]. [Full Text].
Leder K, Weller P. Epidemiology; pathogenesis; and clinical features of schistosomiasis. UpToDate [serial online]. April 24, 2009;1-9. Accessed Sept. 20,2010. Available at http://www.uptodate.com.
Sturrock RF. The Schistosomiasis and their intermediate hosts. In: Mahmood AAF. Schistosomiasis. Imperial College London; 2001:7-83.
Lesham E, Meltzer E, Marva E, Schwartz E. Travel-related Schistosomiasis Acquired in Laos. Emerging Infectious Diseases [serial online]. 15:1823. Available at http://www.cdc.gov/eid.
Epidemiological situation. WHO. Available at http://www.who.int/schistosomiasis/epidemiology/en. Accessed Sept. 27,2010.
WHO-TDR. World health organization. Available at http://www.who.int/tdr. Accessed Oct. 5,2010.
Friedman JF, Mital P, Kanzaria HK, Olds GR, Kurtis JD. Schistosomiasis and pregnancy. Trends Parasitol. Apr 2007;23(4):159-64. [Medline].
Kabatereine N, Brooker S, Tukahebwa E, et al. Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control. Trp Med Int Health. 2004;9:372.
Hagan P, Gryeels B. Schistosomiasis research and the European Community. Trop geogr Med. 1994;46:256.
King CH, Keating CE, Muruka JF, Ouma JH, Houser H, Siongok TK. Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg. Oct 1988;39(4):361-8. [Medline].
Badmos KB, Komolafe AO, Rotimi O. Schistosomiasis presenting as acute appendicitis. East Afr Med J. Oct 2006;83(10):528-32. [Medline].
Terada T. Schistosomal appendicitis: incidence in Japan and a case report. World J Gastroenterol. Apr 7 2009;15(13):1648-9. [Medline]. [Full Text].
Argemi X, Camuset G, Abou-Bakar A, et al. Case report: rectal perforation caused by Schistosoma haematobium. Am J Trop Med Hyg. Feb 2009;80(2):179-81. [Medline].
Lapa M, Dias B, Jardim C, Fernandes CJ, Dourado PM, Figueiredo M. Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation. Mar 24 2009;119(11):1518-23. [Medline].
Nmorsi O, Ukwandu N, Egwungenya O, Obhiemi N. Evaluation of CD4(+)/CD8(+) status and urinary tract infections associated with urinary schistosomiasis among some rural Nigerians. Afr Health Sci. Jun 2005;5(2):126-30. [Medline]. [Full Text].
John R, Ezekiel M, Philbert C, Andrew A. Schistosomiasis transmission at high altitude crater lakes in western Uganda. BMC Infect Dis. Aug 11 2008;8:110. [Medline]. [Full Text].
King CH. Toward the elimination of schistosomiasis. N Engl J Med. Jan 8 2009;360(2):106-9. [Medline].
Wang LD, Chen HG, Guo JG, et al. A strategy to control transmission of Schistosoma japonicum in China. N Engl J Med. Jan 8 2009;360(2):121-8. [Medline].
Wang LD, Guo JG, Wu XH, et al. China's new strategy to block Schistosoma japonicum transmission: experiences and impact beyond schistosomiasis. Trop Med Int Health. Dec 2009;14(12):1475-83. [Medline].
Kallestrup P, Zinyama R, Gomo E, et al. Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection. Clin Infect Dis. Jun 15 2006;42(12):1781-9. [Medline].
Mwanakasale V, Siziya S, Mwansa J, Koukounari A, Fenwick A. Impact of iron supplementation on schistosomiasis control in Zambian school children in a highly endemic area. Malawi Med J. Mar 2009;21(1):12-8. [Medline].
Vennervald BJ, Dunne DW. Morbidity in schistosomiasis: an update. Curr Opin Infect Dis. Oct 2004;17(5):439-47. [Medline].
Savioli L, Crompton DW, Neira M. Use of anthelminthic drugs during pregnancy. Am J Obstet Gynecol. Jan 2003;188(1):5-6. [Medline].
Leshem E, Maor Y, Meltzer E, Assous M, Schwartz E. Acute Schistosomiasis Outbreak: Clinical Features and Economic Impact. Clinical Infectious Diseases. Dec/2008;47:1499-1506.
Mosunjac MB, Tadros T, Beach R, et al. Cervical schistosomiasis, human papilloma virus (HPV), and human immunodeficiency virus (HIV): a dangerous coexistence or coincidence?. Gynecol Oncol. Jul 2003;90(1):211-4. [Medline].
Leutscher PD, Ramarokoto CE, Hoffmann S, Jensen JS, Ramaniraka V, Randrianasolo B. Coexistence of urogenital schistosomiasis and sexually transmitted infection in women and men living in an area where Schistosoma haematobium is endemic. Clin Infect Dis. Sep 15 2008;47(6):775-82. [Medline].
Walker M, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis. Apr 1 2005;40(7):1005-15. [Medline].
Wan H, Lei D, Mao Q. Cerebellar schistosomiasis: a case report with clinical analysis. Korean J Parasitol. Mar 2009;47(1):53-6. [Medline].
Ross AG, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect Dis. Mar 2007;7(3):218-24. [Medline].
Abdel-Wahab MF, Esmat G, Farrag A, el-Boraey YA, Strickland GT. Grading of hepatic schistosomiasis by the use of ultrasonography. Am J Trop Med Hyg. Apr 1992;46(4):403-8. [Medline].
Fowler R, Lee C, Keystone JS. The Role Of Corticosteroids In The Treatment Of Cerebral Schistosomiasis Caused By Schistosoma mansoni: Case Report and Discussion. Am J Trop Med Hyg. 1999;6(1):47-50.
Sandoval N, Siles-Lucas M, Pérez-Arellano JL, Carranza C, Puente S, López-Abán J. A new PCR-based approach for the specific amplification of DNA from different Schistosoma species applicable to human urine samples. Parasitology. Nov 2006;133(Pt 5):581-7. [Medline].
Lier T, Simonsen GS, Haaheim H, Hjelmevoll SO, Vennervald BJ, Johansen MV. Novel real-time PCr for detection of Schistosoma japonicum in stool. Southeast Asian J Trop Med Public Health. Mar 2006;37(2):257-64. [Medline].
Midzi N, Butterworth AE, Mdluza T,et al. Use of circulating cathodic antigen strips for the diagnosis of urinary schistosomiasis. Trans T Soc Trop Med Hyg. 2009;103:45.
Peters P, Kazura JW. Update on diagnostic methods for schistosomiasis. In: Baillere's Clinical Tropical Medicine and Communicable Diseases. 2. 1987.
King C, Mahmouud AA. Schistosomiasis. In: Tropical Infectious Diseases. In: Guerrant R, Walker DH, Weller PF. Principles, Pathogens and Practice,. Vol 2. Philadelphia: Churchill Livingstone; 1999:1031.
Al-Sherbiny MM, Osman AM, Hancock K, et al. Application of immunodiagnostic assays: detection of antibodies and circulating antigens in human schistosomiasis and correlation with clinical findings. Am J Trop Med Hyg. Jun 1999;60(6):960-6. [Medline]. [Full Text].
Sulahian A, Garin YJ, Izri A, Verret C, Delaunay P, van Gool T, et al. Development and evaluation of a Western blot kit for diagnosis of schistosomiasis. Clin Diagn Lab Immunol. Apr 2005;12(4):548-51. [Medline]. [Full Text].
van Lieshout L, Polderman AM, Deelder AM. Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections. Acta Trop. Oct 23 2000;77(1):69-80. [Medline].
ten Hove RJ, Verweij JJ, Vereecken K, et al. Multiplex real-time PCR for the detection and quantification of Schistosoma mansoni and Schistosoma hematobium infection in stool samples collected in northern Senegal. Trans R Soc Trop Med Hyg. 2008;102:179.
Caffrey CR. Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol. Aug 2007;11(4):433-9. [Medline].
Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. Sep 23 2006;368(9541):1106-18. [Medline].
Harries AD, Fryatt R, Walker J, Chiodini PL, Bryceson AD. Schistosomiasis in expatriates returning to Britain from the tropics: a controlled study. Lancet. Jan 11 1986;1(8472):86-8. [Medline].
Shimazu C, Pien FD, Parnell D. Bronchoscopic diagnosis of Schistosoma japonicum in a patient with hemoptysis. Respir Med. Jul 1991;85(4):331-2. [Medline].
Schaberg T, Rahn W, Racz P, Lode H. Pulmonary schistosomiasis resembling acute pulmonary tuberculosis. E Respir J. 1991;4:1023.
Ferrari TC. Spinal cord schistosomiasis. A report of 2 cases and review emphasizing clinical aspects. Medicine (Baltimore). 1999;78:176.
Fenwick A, Rollinson D, Southgate V. Implementation of human schistosomiasis control: Challenges and prospects. Adv Parasitol. 2006;61:567-622. [Medline].
Olds GR. Administration of praziquantel to pregnant and lactating women. Acta Trop. May 2003;86(2-3):185-95. [Medline].
Ismail M, Botros S, Metwally A, et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg. Jun 1999;60(6):932-5. [Medline].
Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg. Aug 1996;55(2):214-8. [Medline].
Adam I, Elwasila el T, Homeida M. Is praziquantel therapy safe during pregnancy?. Trans R Soc Trop Med Hyg. Sep 2004;98(9):540-3. [Medline].
Leder K, Weller PF. Treatment and prevention of schistosomiasis. Available at http://www.uptodate.com. Accessed 9/20/2010.
Tweyongyere R, Mawa PA, Ngom-Wegi S, et al. Effect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial. J Infect Dis. Dec 15 2008;198(12):1870-9. [Medline]. [Full Text].
N'Goran EK, Utzinger J, Gnaka HN, et al. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. Am J Trop Med Hyg. Jan 2003;68(1):24-32. [Medline]. [Full Text].
Posey DL, Blackburn BG, Weinberg M, Flagg EW, Ortega L, Wilson M. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Clin Infect Dis. Nov 15 2007;45(10):1310-5. [Medline].
Ramaswamy K, He YX, Salafsky B, Shibuya T. Topical application of DEET for schistosomiasis. Trends Parasitol. Dec 2003;19(12):551-5. [Medline].
World Health Organization. Preventive chemotherapy in human helminthiasis. Geneva: World Health Organization; November, 2006. [Full Text].
Utzinger J, Keiser J, Shuhua X, et al. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother. May 2003;47(5):1487-95. [Medline]. [Full Text].
Keiser J, N'Guessan NA, Adoubryn KD, Silué KD, Vounatsou P, Hatz C. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis. May 1 2010;50(9):1205-13. [Medline].
| Species | Geographical distribution | |
| Intestinal schistosomiasis | Schistosoma mansoni (mesenteric venules of the colon) | Africa, the Middle East, the Caribbean, and South America |
| Schistosoma japonicum (mesenteric venules of the small intestine) | Asia only: China, Indonesia, the Philippines, and Thailand | |
| Schistosoma mekongi (mesenteric venules of the small intestine) | Several districts of Cambodia and the Lao People’s Democratic Republic. 200-km area of Mekong river basin; now extending toward northern provinces | |
| Schistosoma intercalatum (mesenteric venules of the colon) and related S guineensis | Rain forest areas of Central and West Africa | |
| Urogenital schistosomiasis | Schistosoma haematobium (vesical venous plexus) | Africa, the Middle East, India, and Turkey |

